SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Gränse Lotta)
 

Search: WFRF:(Gränse Lotta) > Dexamethasone eye-d...

Dexamethasone eye-drops for treatment of retinopathy of prematurity

Öhnell, Hanna Maria (author)
Lund University,Lunds universitet,Oftalmologi (Malmö),Forskargrupper vid Lunds universitet,Ophthalmology (Malmö),Lund University Research Groups,Skåne University Hospital
Andreasson, Sten (author)
Lund University,Lunds universitet,Oftalmologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Ophthalmology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital
Gränse, Lotta (author)
Lund University,Lunds universitet,Oftalmologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Ophthalmology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital
 (creator_code:org_t)
Elsevier BV, 2022
2022
English.
In: Ophthalmology Retina. - : Elsevier BV. - 2468-6530. ; 6:2, s. 181-182
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Both studies on animals and humans have demonstrated the role of inflammatory mediators on the retinopathy process.2,3 Dexamethasone is a glucocorticoid with a known reductive effect on several of these mediators and on the expression of VEGF.4Starting in 2016, infants receiving laser ablation for type 1 ROP at Skåne University Hospital were administered dexamethasone eye-drops postoperatively, usually three times daily. None of the infants receiving postoperative topical steroids needed retreatment, in comparison to a general retreatment frequency of 26% nationally when postoperative dexamethasone wasn’t administered routinely.5 During 2018 and 2019, two premature infants started the dexamethasone regimen before the planned laser treatment could be performed and in one the laser could be postponed, in the other the laser treatment was cancelled. Successively, several other infants with type 2 ROP that were considered at very high risk of requiring laser ablation were administered dexamethasone drops preoperatively and the regression of ROP changes were observed on multiple occasions. Consequently, for infants with type 2 ROP born in 2020, all were administered dexamethasone drops before the laser treatment, but usually in a lower dosage of one drop daily.We therefore aim to compare the treatment frequency for screened infants in the southern healthcare region of Sweden born during 2016 through 2020 to make a systematic retrospective analysis to compare dexamethasone treated and untreated infants.The retrospective study was carried through in accordance with the declaration of Helsinki and received ethical approval from the Swedish ethical board. The study followed the Strengthening and Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cohort studies.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Oftalmologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Ophthalmology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Pediatrik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Pediatrics (hsv//eng)

Keyword

Retinopathy of prematurity
Dexamethasone

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Öhnell, Hanna Ma ...
Andreasson, Sten
Gränse, Lotta
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Ophthalmology
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Pediatrics
Articles in the publication
Ophthalmology Re ...
By the university
Lund University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view